Cell 'Snowball' Revolutionizes Tissue Engineering

New biohybrid spheroids could enable large-scale tissue engineering and organ biofabrication.

Apr. 7, 2026 at 5:44am

A bold, abstract painting in soft earth tones depicting the intricate, self-assembling structure of biohybrid cell spheroids, visualizing the innovative technology's potential to transform tissue engineering.Innovative biohybrid cell spheroids could revolutionize tissue engineering by enabling large-scale fabrication of complex biological structures.Penn State Erie Today

Researchers at Penn State have developed a new technology called biohybrid spheroids - a mixture of living cells and microgels - that can rapidly self-assemble or 'snowball' in size while still allowing oxygen and nutrients to reach the cells inside. This addresses key limitations of traditional cell spheroids used in tissue engineering, paving the way for commercial-scale tissue fabrication and organ biofabrication.

Why it matters

Cell spheroids, 3D versions of cell cultures, are an important tool for modeling real tissue and advancing biological research. However, current spheroids face challenges with nutrient and oxygen delivery, limiting their size and function. The new biohybrid spheroid technology developed at Penn State could help overcome these limitations and enable more realistic tissue models and large-scale tissue engineering applications.

The details

The biohybrid spheroids are created by mixing living cells with microgels, tiny materials that mimic the supportive extracellular matrix found in the body. This allows the spheroids to rapidly self-assemble or 'snowball' in size while still enabling oxygen and nutrients to reach the inner cells. Traditional cell spheroids struggle with these issues, as the outer layer blocks delivery of essential compounds to the core.

  • The research was published in the journal Advanced Science in April 2026.

The players

Amir Sheikhi

An associate professor and Dorothy Foehr Huck and J. Lloyd Huck Early Career Chair in Biomaterials and Regenerative Engineering at Penn State.

Penn State

The university where the biohybrid spheroid technology was developed.

National Heart, Lung, and Blood Institute of the National Institutes of Health

The organization that partially funded the research.

Got photos? Submit your photos here. ›

What they’re saying

“Cell spheroids, 3D versions of cell cultures built using a process known as cell aggregation, are the next step in advancing this work, capable of more closely modeling real tissue.”

— Amir Sheikhi, Associate Professor, Penn State

What’s next

The team plans to further develop the biohybrid spheroids to more closely mimic the properties of real tissue, with the goal of enabling commercial-scale tissue engineering and organ biofabrication.

The takeaway

This new biohybrid spheroid technology represents a significant advancement in tissue engineering, overcoming key limitations of traditional cell spheroids and paving the way for more realistic tissue models and large-scale fabrication of engineered tissues and organs.